Trupanion (TRUP) Scheduled to Post Earnings on Wednesday

Trupanion (NASDAQ:TRUP) will be releasing its earnings data after the market closes on Wednesday, October 30th. Analysts expect Trupanion to post earnings of ($0.06) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. During the same quarter in the previous year, the firm posted ($0.33) EPS. The firm’s quarterly revenue was up 16.3% on a year-over-year basis. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Trupanion Stock Performance

NASDAQ TRUP opened at $52.60 on Wednesday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average is $45.47 and its two-hundred day moving average is $34.73. Trupanion has a 12-month low of $19.14 and a 12-month high of $55.74. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of -116.89 and a beta of 1.73.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,764 shares of company stock valued at $405,238. 5.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on TRUP shares. Stifel Nicolaus boosted their price target on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Bank of America boosted their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Northland Securities boosted their price target on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Piper Sandler boosted their price target on Trupanion from $38.00 to $45.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 2nd. Finally, Evercore ISI raised Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.83.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.